Interfering with HDL cholesterol pharmaceutically may be inappropriate, as suggested by the difficulty in developing a patented HDL-raising medication.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.